Published: 2022-08-24

Treatment of benign positional paroxysmal vertigo in clinical settings in India: a cross sectional pilot survey

Sreeram P., Prabash Prabhakaran


Background: The usage pattern and effectiveness of various treatment strategies for benign positional paroxysmal vertigo (BPPV) have not been widely reported in routine clinical settings in India. The aim of the study was to understand treatment patterns and level of symptom improvement in Indian patients presenting with symptoms of BPPV in clinical practice.

Methods: A cross-sectional pan-India survey was conducted with leading neurologists and otolaryngologists. A detailed questionnaire was shared with specialists which was followed by semi-structured telephonic interviews to gather a deeper understanding of their treatment practices. The obtained data was analyzed using appropriate statistical methods.

Results: A total of 5 neurologists and 8 ENT specialists completed the survey. Physicians reported that age, but not gender, was an important factor when selecting appropriate treatment. Specialists reported that in their clinical practice symptom improvement is better with betahistine plus maneuvers compared to betahistine only alone (97% verses 90% cure rate) and is comparable with maneuvers (97% verses 98% cure rate, respectively). Dix Hallpike and supine roll test using videonystagmography were the most recommended tests used to diagnose BPPV. Betahistine plus maneuvers was the most commonly prescribed treatment for BPPV, and clinicians observed greater decrease in the severity of BPPV symptoms with betahistine plus maneuvers versus betahistine alone or maneuvers. The Visual analog scale (VAS) was the most widely used scale for assessing severity of BPPV symptoms.

Conclusions: These findings indicate that betahistine plus maneuvers provides better control over symptom severity in patients with BPPV.




BPPV, Betahistine, Maneuvers, VAS, Real world study

Full Text:



Von Brevern M, Radtke A, Lezius F, Feldmann M, Ziese T, Lempert T et al. Epidemiology of benign paroxysmal positional vertigo: A population-based study. J Neurol Neurosurg Psychiatry. 2007;78(7):710-5.

Sanchez-Vanegas G, Castro-Moreno C, Buitrago D. Betahistine in the treatment of peripheral vestibular vertigo: Results of a real-life study in primary care. Ear, Nose Throat J. 2020;99(6):356-60.

Benecke H, Pérez-Garrigues H, Bin Sidek D, Uloziene I, Kuessner D, Sondag E et al. Effects of betahistine on patient-reported outcomes in routine practice in patients with vestibular vertigo and appraisal of tolerability: Experience in the OSVaLD study. Int Tinnitus J. 2010;16(1):14-24.

Barnes E, Bunka D, Tolley A. Targeted treatment. EBR-Eur Biopharm Rev. 2018;2018(7):38-44.

Yardley L, Redfern MS. Psychological factors influencing recovery from balance disorders. J Anxiety Disord. 2001;15(1-2):107-19.

Fife TD, Iverson DJ, Lempert T, Furman JM, Baloh RW, Tusa RJ et al. Practice parameter: therapies for benign paroxysmal positional vertigo (an evidence-based review): Report of the quality standards subcommittee of the american academy of neurologysymbol symbol. Neurology. 2008;70(22):2067-74.

Kim J-S, Zee DS. Clinical practice. Benign paroxysmal positional vertigo. N Engl J Med. 2014;370(12):1138-47.

Parnes LS, Nabi S. The diagnosis and management of benign paroxysmal positional vertigo. Semin Hear. 2009;30(4):287-305.

Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol. 2007;20(1):40-6.

Helminski JO, Zee DS, Janssen I, Hain TC. Effectiveness of particle repositioning maneuvers in the treatment of benign paroxysmal positional vertigo: A systematic review. Phys Ther. 2010;90(5):663-78.

Lawson J, Johnson I, Bamiou DE, Newton JL. Benign paroxysmal positional vertigo: Clinical characteristics of dizzy patients referred to a Falls and Syncope Unit. QJM-Mon J Assoc Physicians. 2005;98(5):357-64.

Murdin L, Hussain K, Schilder AGM. Betahistine for symptoms of vertigo. Cochrane Database Syst Rev. 2013;2013(8).

Parfenov VA, Golyk VA, Matsnev EI, Morozova SV, Melnikov OA, Antonenko LM et al. Effectiveness of betahistine (48 mg/day) in patients with vestibular vertigo during routine practice: The VIRTUOSO study. PLoS One. 2017;12(3):1-11.

Kaur J, Shamanna K. Management of benign paroxysmal positional vertigo: A comparative study between epleys manouvre and betahistine. Int Tinnitus J. 2017;21(1):30-4.